Clinical Trials Logo

Filter by:
NCT ID: NCT04735926 Completed - Clinical trials for Vitamin D Deficiency

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency

WORFEROL
Start date: December 23, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

This is a randomised, double-blind, double-dummy, multicentre, dose-ranging clinical trial in subjects with vitamin D deficiency or insufficiency. Its general objective is to determine the efficacy and safety of different doses of calcifediol soft gelatin capsules (SGCs) compared to placebo.

NCT ID: NCT04735432 Completed - Clinical trials for Generalized Myasthenia Gravis

Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis

ADAPTsc
Start date: February 5, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the Pharmacodynamics (PD), Pharmacokinetics (PK), safety, tolerability, immunogenicity, and clinical efficacy of efgartigimod coformulated with recombinant human hyaluronidase PH20 (rHuPH20) as compared to efgartigimod IV infused in patients with generalized myasthenia gravis (gMG). The study duration is approximately 12 weeks. After screening, patients will be randomized to receive either efgartigimod infusions or efgartigimod PH20 subcutaneously (SC)

NCT ID: NCT04734561 Completed - Covid19 Clinical Trials

Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease

Start date: February 8, 2021
Phase: N/A
Study type: Interventional

The main objective of the present study is to observe the short-term effects of respiratory muscle training applied by telerehabilitation on quality of life and exercise tolerance in people who have had the COVID-19 disease. As secondary objectives, the effects on respiratory muscles strength/tolerance, pulmonary function and psychological and cognitive factors.

NCT ID: NCT04734548 Completed - Stroke Clinical Trials

Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke

Start date: October 28, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is a prospective, multicenter, double-blind, randomized, placebo-controlled, Phase Ib/IIa clinical study to assess the administration of ApTOLL together with endovascular therapy in acute ischemic stroke patients who are candidates to receive reperfusion therapies.

NCT ID: NCT04734132 Completed - PreDiabetes Clinical Trials

Effects of Moringa Oleifera Leaves on Glycemia, Lipemia and Inflammatory Profile in Prediabetic Patients

NUTRIMOL-DB
Start date: January 22, 2019
Phase: N/A
Study type: Interventional

Moringa oleifera (MO) is a traditional food in tropical and subtropical areas and has attained a growing interest for its medicinal properties. It's a nutrient-rich vegetable, high in protein and polyphenol content. The MO dry leaves and leaf extracts have been shown to exert numerous in vitro activities and in vivo effects, including the hypoglycemic effect. Thus, MO could be an alternative to prevent or treat diabetes. Studies in humans, however, are still limited. This proposal aims to study the efficacy of Moringa oleifera to improve the control of glycaemia in subjects with prediabetes. A 3-month dietary intervention with MO dry leave capsules will be performed and compared to placebo.

NCT ID: NCT04732949 Completed - COVID-19 Clinical Trials

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

SPRINTER
Start date: January 12, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this Phase III study is to confirm that SNG001 can accelerate the recovery of hospitalised patients receiving oxygen with confirmed Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). Safety and other efficacy endpoints will also be assessed.

NCT ID: NCT04732494 Completed - Clinical trials for Esophageal Squamous Cell Carcinoma

AdvanTIG-203: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Start date: March 31, 2021
Phase: Phase 2
Study type: Interventional

A study of tislelizumab (BGB-A317) plus ociperlimab versus tislelizumab plus placebo as second-line treatment in participants with programmed cell death protein-ligand 1 (PD-L1) tumor area positivity (TAP) ≥ 10% unresectable, locally advanced, recurrent or metastatic esophageal squamous cell carcinoma.

NCT ID: NCT04732286 Completed - Clinical trials for Carcinoma, Hepatocellular

A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy

Start date: May 4, 2021
Phase: Phase 3
Study type: Interventional

This is a Phase IIIb, one arm, multicenter, open-label study primarily designed to evaluate the safety of atezolizumab + bevacizumab in participants with unresectable or unsuitable for locoregional treatments for metastatic HCC not previously treated with systemic therapy. As part of its secondary objectives, this study is also designed to evaluate the efficacy of atezolizumab and bevacizumab in these participants.

NCT ID: NCT04732078 Completed - Old Age Clinical Trials

Physical and Mental Characteristics in Active Elderly People

ActivOld
Start date: February 4, 2021
Phase:
Study type: Observational

Today's world is characterized among other things by a progressive increase in the aging population, due to a decrease in the birth rate and an increase in life expectancy. In developed countries, the number of older people is increasing, largely due to significant advances in health sciences and new life habits. The aim of this study is to describe an active population over 60 years old, which complies with the concept of successful aging, in order to know its characteristics both at a physical and mental health level and to be able to make recommendations from physiotherapy. Active people over 60 years of age recruited from two associations (Amics de la Nau Gran, and Hogares) from the city of Valencia, Spain will be part of the study. Pain was assessed using the Visual Analogue Scale, the level of physical activity performed using the IPAQ questionnaire, quality of life using the SF-12v2, sleep quality using the Pittsburg questionnaire, and mood using the depression scale and Goldberg's anxiety, as well as functional tests to assess respiratory status.

NCT ID: NCT04730856 Completed - Covid19 Clinical Trials

Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The main objective is to evaluate the efficacy and safety of three doses of tinzaparin (prophylactic, intermediate and therapeutic) in hospitalized patients with COVID-19 pneumonia.